Abstract
In the present work Repaglinide loaded ammonio methacrylate copolymer nanoparticles were developed by modified solvent emulsion technique using high pressure homogenizer. An effect of numerous organic solvents, surfactant concentration, drug-polymer ratios and combination of polymers on encapsulation efficiency as well as drug release profile were studied. Sustained released nanoparticles were obtained in the size of less than 400 nm. FE-SEM showed smooth and rigid surface of Eudragit RS nanoparticle’s while porous surface nature was observed in Eudragit RL nanoparticles. No drug-polymer interaction was found. X-RD revealed that the crystallinity of repaglinide was decreased when processed with Eudragit polymers. Eudragit RSPO retained drug for more time than other copolymers. Most of the formulations followed zero order kinetics. Prepared nanoparticles can be used for the treatment of type 2 diabetes mellitus by minimizing dose rate, reducing adverse effects and enhancing patient fulfillment.
Keywords: Drug release study, eudragit RL, eudragit RS, modified emulsification, stability study.
Micro and Nanosystems
Title:Effect of Solvents, Drug/Polymer Ratio and Surfactant Concentration on In Vitro Characteristic of Repaglinide Loaded Poly (Meth) Acrylate Nanoparticles
Volume: 6 Issue: 4
Author(s): A. Lokhande, S. Mishra, R. Kulkarni and J. Naik
Affiliation:
Keywords: Drug release study, eudragit RL, eudragit RS, modified emulsification, stability study.
Abstract: In the present work Repaglinide loaded ammonio methacrylate copolymer nanoparticles were developed by modified solvent emulsion technique using high pressure homogenizer. An effect of numerous organic solvents, surfactant concentration, drug-polymer ratios and combination of polymers on encapsulation efficiency as well as drug release profile were studied. Sustained released nanoparticles were obtained in the size of less than 400 nm. FE-SEM showed smooth and rigid surface of Eudragit RS nanoparticle’s while porous surface nature was observed in Eudragit RL nanoparticles. No drug-polymer interaction was found. X-RD revealed that the crystallinity of repaglinide was decreased when processed with Eudragit polymers. Eudragit RSPO retained drug for more time than other copolymers. Most of the formulations followed zero order kinetics. Prepared nanoparticles can be used for the treatment of type 2 diabetes mellitus by minimizing dose rate, reducing adverse effects and enhancing patient fulfillment.
Export Options
About this article
Cite this article as:
Lokhande A., Mishra S., Kulkarni R. and Naik J., Effect of Solvents, Drug/Polymer Ratio and Surfactant Concentration on In Vitro Characteristic of Repaglinide Loaded Poly (Meth) Acrylate Nanoparticles, Micro and Nanosystems 2014; 6 (4) . https://dx.doi.org/10.2174/187640290604150302125610
DOI https://dx.doi.org/10.2174/187640290604150302125610 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Efficacy of Psychological Therapies for Specific Phobias in Adults and Some Unanswered Questions
Current Psychiatry Reviews Hypoxia-inducible Factor-1α Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis
Anti-Cancer Agents in Medicinal Chemistry Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling
Current Medicinal Chemistry Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
Current Medicinal Chemistry Nuclear Hormone Receptors and Female Reproduction
Current Molecular Medicine Lipid Composition of Cell Membranes and Its Relevance in Type 2 Diabetes Mellitus
Current Diabetes Reviews Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions
Current Topics in Medicinal Chemistry Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis
Current Drug Metabolism Perfusion-diffusion Mismatch Predicts Early Neurological Deterioration in Anterior Circulation Infarction without Thrombolysis
Current Neurovascular Research Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Experimental Diabetes Mellitus Down-Regulates Large-Conductance Ca2+- Activated K+ Channels in Cerebral Artery Smooth Muscle and Alters Functional Conductance
Current Neurovascular Research GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
Current Alzheimer Research Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders
Current Vascular Pharmacology Obesity and Diabetes Gene Discovery Approaches
Current Pharmaceutical Design Current Status of Therapeutic Angiogenesis with Protein, Gene and Cell Therapy
Current Drug Therapy Mental Health Patients at High Risk for Obesity, Type 2 Diabetes, and Cardiovascular Disease: An Australian Perspective
Current Hypertension Reviews BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients
Recent Patents on Anti-Cancer Drug Discovery Sodium-glucose Cotransporter 2 Inhibitors: The Pleiotropic Mechanisms of Actions
Cardiovascular & Hematological Disorders-Drug Targets Editorial:Nutrition Transition in Developing Countries: Focus on South Asia
Current Diabetes Reviews